KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) FCF Margin (2018 - 2025)

ClearPoint Neuro's FCF Margin history spans 13 years, with the latest figure at 37.47% for Q3 2025.

  • For Q3 2025, FCF Margin fell 2256.0% year-over-year to 37.47%; the TTM value through Sep 2025 reached 39.61%, down 1034.0%, while the annual FY2024 figure was 29.55%, 3072.0% up from the prior year.
  • FCF Margin for Q3 2025 was 37.47% at ClearPoint Neuro, down from 27.39% in the prior quarter.
  • Across five years, FCF Margin topped out at 14.91% in Q3 2024 and bottomed at 107.91% in Q2 2021.
  • The 5-year median for FCF Margin is 59.99% (2022), against an average of 60.4%.
  • The largest annual shift saw FCF Margin tumbled -3898bps in 2021 before it skyrocketed 5682bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 83.84% in 2021, then rose by 28bps to 59.99% in 2022, then soared by 71bps to 17.47% in 2023, then dropped by -15bps to 20.02% in 2024, then crashed by -87bps to 37.47% in 2025.
  • Per Business Quant, the three most recent readings for CLPT's FCF Margin are 37.47% (Q3 2025), 27.39% (Q2 2025), and 73.07% (Q1 2025).